"Conventional drugs have poor therapeutic effects due to their poor specificity and stability. With the development of nanotechnology, nonviral nanoparticles bring hope for the efficient treatment of leukemia. Nanoparticles are easily modified."
https://pubmed.ncbi.nlm.nih.gov/33320613/
"ZnO NPs may provide a new basis and idea for treating human acute myeloid leukemia in clinical practice."
https://pubmed.ncbi.nlm.nih.gov/35383422
CuO nanoparticles induce cytotoxicity and apoptosis in human K562 cancer cell line via mitochondrial pathway, through reactive oxygen species and P53
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686584/
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
https://pubmed.ncbi.nlm.nih.gov/26929621/